Recent Stories
Keeping the Human in Medicine: Two AI CoLab Researchers on What Machines Can’t ReplaceSomeone Is Hacking the Freezers. Pay Attention.Thinking of Running in 2028? Start HereWhat the Lame Duck Session Has to Do With the Ultimate 21st-Century Power Tool: RobotsBlack October Wasn't an Attack Wave. It Was a Warning.Extreme Ownership Means Ultimate Achievement – NASA Culture Shift
← Back to the board
Money

NIH seeks applications for translational genome editing and biologic therapy development for Alzheimer's-related dementias, with a $6 million ceiling.

Why it’s here: NIH NOFO funding translation of genome editing and biologic therapies (CRISPR-type editing, cell/gene-adjacent biologics) through IND-enabling studies, which falls under biotechnology's federal policy and NIH program areas.

Trace across the board

Item

Coverage

1 outlets · first seen oct 13

Connected

12 links

About

  • National Institutes of Health
  • Department of Health and Human Services

Analytics cookies help us see how the site is used. They only run if you accept. Privacy Policy

NIH seeks applications for translational genome editing and biologic therapy development for Alzheimer's-related dementias, with a $6 million ceiling. — The Wave